去甲氯氮平,desmethylclozapine英语短句,例句大全

去甲氯氮平,desmethylclozapine
1)desmethylclozapine去甲氯氮平
1.RESULTS: Significant differences were found between the plasma concentrations of clozapine and desmethylclozapine and clinical efficacy, especially desmethylclozapine plasma concentration.结果 :氯氮平及去甲氯氮平血药浓度与临床疗效有明显关系 ,尤以去甲氯氮平血药浓度与临床疗效关系更为密切。
2)norclozapine去甲氯氮平
1.A HPLC method for determination of clozapine and norclozapine in human plasma was established.建立了HPLC法测定人血浆中的氯氮平及去甲氯氮平含量。
3)removal efficiency of ammonia nitrogen氨氮去除氯
4)clozapine氯氮平
1.Spectrometric Study on the Interaction between Clozapine and Bovine Serum Albumin;氯氮平与蛋白质相互作用的研究
2.A control study of clozapine plus fluoxetine in schizophrenia with depressive symptoms;氯氮平联合氟西汀治疗精神分裂症伴抑郁症状对照研究
3.A control study on aripiprazole vs. clozapine in the treatment of refractory schizophrenia;阿立哌唑与氯氮平治疗难治性精神分裂症对照研究

英文短句/例句

1.A controlled study between olanzapine and clozapine in the treatment of schizophrenia奥氮平与氯氮平治疗精神分裂症临床对照观察
2.The contrasting of the treatment in psychiatric symptoms of Parkinson's disease by olanzapine and clozapine奥氮平与氯氮平治疗巴金森病精神症状的对照
3.Simultaneous Determination of Clozapine, Olanzapine and Mirtazapine in Human Plasma by LC-MS/MSLC-MS/MS同时测定人血浆中氯氮平、奥氮平和米氮平
4.Objectives: To compare the different effect of clozapine and chlorpromazine on serum salivary acid.目的比较氯氮平和氯丙嗪对血清唾液酸的影响。
5.The protein binding selectivity of clozapine was discussed.讨论了氯氮平蛋白结合作用的选择性。
6.Effectiveness of Oryzanol in the Treatment of Clozapine-induced Salivation Reaction谷维素治疗氯氮平流涎反应效果观察
7.Investigation of metabolic syndrome in inpatients of chronic schizophrenia with long-term clozapine treatment长期氯氮平治疗引发代谢综合征调查
8.Preparation and Quality Control of Clozapine Oral Disintegrating Tablets氯氮平口腔崩解片的制备及质量控制
9.Efficacy of quetiapine and clozapine in treatment of schizophrenia喹硫平与氯氮平治疗慢性精神分裂症对照研究
10.Efficacy and safety of clozapine or olanzapine in combination with other antischizophrenic drugs氯氮平、奥氮平与其他抗精神分裂症药物联用的疗效与安全性
11.Effects of olanzapine and clozapine on cognitive function in chronic schizophrenia奥氮平和氯氮平对慢性精神分裂症的认知功能的影响
12.Parotid enlargement has previously been described in patients receiving clozapine.以往曾有接受氯氮平治疗引起腮腺肿大的报告。
13.An Analysis of the Cardiac Side Effects and Cardiotoxicity Associated with Clozapine and the Involved Risk Factors;氯氮平所致心脏毒副反应及危险因素分析
14.Study of postmortem redistribution of clozapine in rabbit;氯氮平在家兔体内死后再分布规律研究
15.Determination of the Concentration of Clozapine in Human Plasma by HPLC with UV Detection;高效液相色谱法测定人血浆中氯氮平浓度
16.GC/MS analysis of clozopine in burned internal organs tissue of human body;GC/MS法分析被焚烧人体内脏组织中的氯氮平
17.Pharmacokinetics of Clozapine Orally Disintegrating Tablets in Healthy Volunteers氯氮平口腔崩解片在健康人体的药动学研究
18.Effects of clozapine on plasma neuropeptide Y (NPY) levels and body weight regulations氯氮平对血浆神经肽Y及体质量的影响

延伸阅读

氯氮平【通用名称】氯氮平【其他名称】氯氮平氯氮平拼音名：Ludanping 英文名：Clozapine 书页号：2000年版二部－923 C18H19ClN4 326.84 本品为8-氯-11-(4- 甲基-1- 哌嗪基)-5H- 二苯并[b,e][1,4]二氮杂{卓}。按干燥品计算，含C18H19ClN4不得少于98.5％。【性状】本品为淡黄色结晶性粉末；无臭，无味。本品在氯仿中易溶，在乙醇中溶解，在不中几乎不溶。熔点本品的熔点（附录Ⅵ C）为181 ～185 ℃。吸收系数取本品，加0.5mol/L硫酸溶液－乙醇(1→99)制成每1ml中约含10μl的溶液，照分光光度法（附录Ⅳ A），在242nm与296nm的波长处测定吸收度，吸收系数（Ｅ 1% 1cm）分别为710～770与293～320。【鉴别】 (1) 取本品约100mg ，加碳酸钠等量搅拌均匀，置干燥试管中灼烧，管口覆以用1％1,2-萘醌-4-磺酸钠溶液湿润的试纸，试液显紫蓝色。 (2) 本品的红外光吸收图谱应与对照的图谱（光谱集504 图）一致。【检查】干燥失重取本品，在105 ℃干燥至恒重，减失重量不得过1.0 ％（附录Ⅷ L）。炽灼残渣不得过0.1％（附录Ⅷ N）。【含量测定】取本品约0.1g，精密称定，加冰醋酸20ml使溶解，加结晶紫指示液 1滴，用高氯酸滴定液(0.1mol/L)滴定至溶液显亮绿色，并将滴定的结果用空白试验校正。每1ml高氯酸滴定液(0.1mol/L)相当于16.34mg的C18H19ClN4。【类别】抗精神病药。【贮藏】遮光，密封保存。【制剂】氯氮平片